iCoreConnect continues to build off its 2021 results delivering
- Annual Recurring Revenue:
$1 .8MM from$0 .9MM (200% growth) - Revenues:
$2 .0MM from$0 .7MM (285% growth) - Subscribers: Increased subscribers by 15,000
The continued traction of the Company’s electronic prescription services, iCoreRx, along with the full launch of its automated insurance verification service, iCoreVerify, contributed to the increase in Annual Recurring Revenues (ARR) to
Subscribers grew by 225% to approximately 27,000 recurring subscribers at
About iCoreConnect
iCoreConnect (OTCQB: ICCT) is a market leading, cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. The company’s philosophy places a high value on customer feedback, allowing iCoreConnect to respond to the market’s needs. iCoreConnect touts a platform of 15 SaaS enterprise solutions and nearly 80 agreements with state or regional healthcare associations across the
Forward-Looking Statements
In this news release, the use of the words "believe," "could," "expect," "may," "positioned," "project," "projected," "should," "will," "would," or similar expressions are intended to identify forward-looking statements that represent the Company's current judgment about possible future events. The Company believes these judgments are reasonable, but these statements are not guarantees of any events or financial results, and actual results may differ materially due to a variety of important factors.
Contact: IR@iCoreConnect.com
Source:
2022 GlobeNewswire, Inc., source